nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Amphetamine-related drugs neurotoxicity in humans and in experimental animals: Main mechanisms
|
Moratalla, Rosario |
|
2017 |
155 |
C |
p. 149-170 22 p. |
artikel |
2 |
CO2: Editorial Board/Subscription info.
|
|
|
2017 |
155 |
C |
p. IFC- 1 p. |
artikel |
3 |
Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease
|
Zucca, Fabio A. |
|
2017 |
155 |
C |
p. 96-119 24 p. |
artikel |
4 |
Involvement of the kynurenine pathway in the pathogenesis of Parkinson’s disease
|
Lim, Chai K. |
|
2017 |
155 |
C |
p. 76-95 20 p. |
artikel |
5 |
Long-term consequences of prenatal stress and neurotoxicants exposure on neurodevelopment
|
Antonelli, Marta C. |
|
2017 |
155 |
C |
p. 21-35 15 p. |
artikel |
6 |
Microglial phenotypes in Parkinson’s disease and animal models of the disease
|
Joers, Valerie |
|
2017 |
155 |
C |
p. 57-75 19 p. |
artikel |
7 |
Models of progressive neurological dysfunction originating early in life
|
Marriott, Amber L. |
|
2017 |
155 |
C |
p. 2-20 19 p. |
artikel |
8 |
Multiple mechanisms of neurodegeneration and progression
|
Herrero, Maria Trinidad |
|
2017 |
155 |
C |
p. 1- 1 p. |
artikel |
9 |
Novel tactics for neuroprotection in Parkinson's disease: Role of antibiotics, polyphenols and neuropeptides
|
Reglodi, Dora |
|
2017 |
155 |
C |
p. 120-148 29 p. |
artikel |
10 |
Protein aggregation and neurodegeneration in prototypical neurodegenerative diseases: Examples of amyloidopathies, tauopathies and synucleinopathies
|
Bourdenx, Mathieu |
|
2017 |
155 |
C |
p. 171-193 23 p. |
artikel |
11 |
The multifaceted role of metalloproteinases in physiological and pathological conditions in embryonic and adult brains
|
De Stefano, Maria Egle |
|
2017 |
155 |
C |
p. 36-56 21 p. |
artikel |
12 |
The Yin and Yang of nucleic acid-based therapy in the brain
|
Gustincich, Stefano |
|
2017 |
155 |
C |
p. 194-211 18 p. |
artikel |